FIRST-IN-HUMAN MULTICENTER STUDY OF BB2121 ANTI-BCMA CAR T CELL THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS Lin, Y., Berdeja, J., Raje, N., Munshi, N., Siegel, D., Liedtke, M., Jagannath, S., Maus, M., Turka, A., Lam, L. P., Hege, K., Morgan, R., Quigley, M. T., Kochenderfer, J. FERRATA STORTI FOUNDATION. 2017: 21

View details for Web of Science ID 000404127001043